Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis.

Cancer Manag Res · 2020 · PMC7398747 · PMID 32801898

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

an obvious trendp=0.051so close (0.05 < p ≤ 0.1)

Response to NAC In the unmatched study, the overall tumor response to NAC was not statistically significant between the two groups, but an obvious trend was seen that the DOS group showed a better tumor response than the SOX group (p=0.051, Table 2 ).

also in 1,006 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.